BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2023 8:11:23 AM | Browse: 203 | Download: 624
 |
Received |
|
2023-06-27 15:09 |
|
Peer-Review Started |
|
2023-06-27 15:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-25 22:17 |
|
Revised |
|
2023-08-07 19:12 |
|
Second Decision |
|
2023-08-16 02:59 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-08-17 02:27 |
|
Articles in Press |
|
2023-08-17 02:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-08-28 00:18 |
|
Publish the Manuscript Online |
|
2023-09-01 08:11 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Giovanni Monaco, Luca Bucherini, Bernardo Stefanini, Fabio Piscaglia, Francesco Giuseppe Foschi and Luca Ielasi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Luca Ielasi, MD, Doctor, Doctor, Department of Internal Medicine, Ospedale degli Infermi di Faenza, Viale Stradone, 9, Faenza 48018, Italy. luca.ielasi.kr@gmail.com |
| Key Words |
Splanchnic vein thrombosis; Portal vein thrombosis; Budd-Chiari syndrome; Direct oral anticoagulants |
| Core Tip |
The term splanchnic vein thrombosis (SVT) includes portal vein thrombosis and Budd-Chiari syndrome. Both conditions could occur in patients with and without an underlying liver disease. The cornerstone of treatment is anticoagulation. Direct oral anticoagulants (DOACs) are a novel class of drugs that have strongly affirmed their role in the management of patients with atrial fibrillation and venous thromboembolism. In the last few years, several studies have been published showing promising results in efficacy and safety of DOACs in patients with SVT. |
| Publish Date |
2023-09-01 08:11 |
| Citation |
Monaco G, Bucherini L, Stefanini B, Piscaglia F, Foschi FG, Ielasi L. Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art. World J Gastroenterol 2023; 29(33): 4962-4974 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i33/4962.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i33.4962 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
